ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 178 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,008 | -4.9% | 2,343 | -7.8% | 0.00% | – |
Q2 2023 | $50,470 | +148341.2% | 2,540 | +27.6% | 0.00% | – |
Q1 2023 | $34 | -98.8% | 1,990 | -98.6% | 0.00% | -100.0% |
Q4 2022 | $2,798 | -92.4% | 142,990 | +7085.4% | 0.02% | – |
Q3 2022 | $37,000 | +60.9% | 1,990 | +17.1% | 0.00% | – |
Q2 2022 | $23,000 | -76.5% | 1,700 | -72.6% | 0.00% | -100.0% |
Q1 2022 | $98,000 | -19.7% | 6,200 | -15.8% | 0.00% | 0.0% |
Q4 2021 | $122,000 | -45.5% | 7,360 | -1.9% | 0.00% | 0.0% |
Q3 2021 | $224,000 | -32.5% | 7,500 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $332,000 | -8.5% | 7,500 | -8.3% | 0.00% | 0.0% |
Q1 2021 | $363,000 | -15.0% | 8,180 | +5.1% | 0.00% | -33.3% |
Q4 2020 | $427,000 | +175.5% | 7,780 | +14.4% | 0.00% | +200.0% |
Q3 2020 | $155,000 | +39.6% | 6,800 | +28.3% | 0.00% | 0.0% |
Q2 2020 | $111,000 | +50.0% | 5,300 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $74,000 | -38.8% | 5,300 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $121,000 | +95.2% | 5,300 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $62,000 | -22.5% | 5,300 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $80,000 | -14.0% | 5,300 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $93,000 | +17.7% | 5,300 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $79,000 | – | 5,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |